Cornelis Boersma

dr.

If you made any changes in Pure these will be visible here soon.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

40 Article
4 Meeting Abstract
3 Editorial
2 Chapter
More

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands
Eijsink, J. F. H., Al Khayat, M. N. M. T., Boersma, C., ter Horst, P. G. J., Wilschut, J. C. & Postma, M. J., Feb-2021, In: European Journal of Health Economics. 22, 1, p. 75-88 14 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

16 Downloads (Pure)
Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands
Hagendijk, M. E., van der Schans, S., Boersma, C., Postma, M. J. & van der Pol, S., 7-Apr-2021, (E-pub ahead of print) In: European Journal of Health Economics. 9 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File
A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics
Geenen, J. W., Belitser, S., Vreman, R. A., van Bloois, M., Klungel, O. H., Boersma, C. & Hovels, A. M., Aug-2020, In: European Journal of Health Economics. 21, 6, p. 845-853 9 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

33 Downloads (Pure)
Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in Indonesia
Suwantika, A. A., Kautsar, A. P., Zakiyah, N., Abdulah, R., Boersma, C. & Postma, M. J., 2020, In: Therapeutics and clinical risk management. 16, p. 969-977 9 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

61 Downloads (Pure)
COST-EFFECTIVENESS OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (PF-ILD) IN THE NETHERLANDS
Westerink, L., Nicolai, J., Postma, M., van Boven, J. F. M. & Boersma, C., 1-Dec-2020, In: Value in Health. 23, p. S716-S717 2 p.
Research output: Contribution to journal › Meeting Abstract › Academic

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics

Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in Indonesia

COST-EFFECTIVENESS OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (PF-ILD) IN THE NETHERLANDS